Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348582 · ClinicalTrials.gov registry record · Phase 4
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00348582: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00348582 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348582, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.
Interventions
- DRUG Ketorolac, Nepafenac
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00348582 record still lists
NCT00348582 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac, Nepafenac is the first listed.
NCT00348582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00348582 about?
NCT00348582 is a clinical study titled "Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery". The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.
What is the current status of trial NCT00348582?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00348582?
The interventions under investigation include: Ketorolac, Nepafenac (DRUG).
Who is sponsoring clinical trial NCT00348582?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.